ArticleInternational journal of cardiology. Heart & vasculature2025

Rationale and design of the STOP-IMH randomised trial: Safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and the effect on intramyocardial haemorrhage.

E C I Woelders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.